Three studies elucidate the proteomic and genomic characteristics of lung cancer and suggest new ways to treat the disease. The first study found distinct mutation patterns in Taiwanese patients, most of whom had never smoked. The second study, which included only Chinese patients, identified three groups with different prognoses. The third study of an international group of patients uncovered three new targets for drug development.

You do not currently have access to this content.